Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/15/2024 | ARMISTICE CAPITAL, LLC | 352,941 | $17,612 | 0.00% | 0.66% |
05/13/2024 | CLEAR STREET LLC | 266,264 | $13,000 | -0.08% | 0.50% |
05/15/2024 | CITADEL ADVISORS LLC | 28,578 | $1,429 | -1.38% | 0.05% |
05/20/2024 | VIRTU FINANCIAL LLC | 12,942 | $1,000 | -45.53% | 0.02% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 88 | $4 | 100.00% | 0.00% |
A. During the previous two years, 6 institutional investors and hedge funds held shares of Heart Test Laboratories, Inc.. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 352,941
CLEAR STREET LLC: 266,264
CITADEL ADVISORS LLC: 28,578
Virtu Financial LLC: 12,942
BANK OF AMERICA CORP /DE/: 88
CITADEL ADVISORS LLC: 28,978
A. 1.23% of Heart Test Laboratories, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 689,791 shares in the last 24 months. This purchase volume represents approximately $41,181 in transactions.